Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$13.18 +0.54 (+4.27%)
At close: Sep 30, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Capital Leases (2015 - 2019)

Updated

Enanta Pharmaceuticals (ENTA) reported Capital Leases of $200,000 for fiscal Q4 2019 (quarter ended Sep 30, 2019), down 31.7% from $293,000 a year earlier and down 10.7% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Capital Leases (2015 - 2019) Analysis & Trends

Dating back to fiscal Q3 2015, Enanta Pharmaceuticals' Capital Leases record includes 18 quarters.

  • Capital Leases has declined for four consecutive fiscal years, with a four-year compound annual growth rate of -21.6% (FY2015 to FY2019).
  • By fiscal year, Capital Leases came in at $293,000 in FY2018 (-22.7%), $379,000 in FY2017 (-17.2%), $458,000 in FY2016 (-13.4%) and $529,000 in FY2015.
  • The fiscal Q4 2019 figure ranks as the lowest quarterly Capital Leases since fiscal Q3 2015.
  • Year over year, Capital Leases has now declined in each of the last 13 quarters, with an average decline of 24.2% over the last eight quarters.
  • The high point for year-over-year Capital Leases in five years was fiscal Q3 2016 (growth of 173.1%); the low point was fiscal Q4 2019 (a decline of 31.7%).
  • Per Business Quant data, the three fiscal quarters before Q4 2019 came in at $224,000 (Q3 2019), $249,000 (Q2 2019) and $271,000 (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Enanta Pharmaceuticals 368.08 Mn -359.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 200,000.00
Jun 30, 2019 224,000.00
Mar 31, 2019 249,000.00
Dec 31, 2018 271,000.00
Sep 30, 2018 293,000.00
Jun 30, 2018 315,000.00
Mar 31, 2018 337,000.00
Dec 31, 2017 358,000.00
Sep 30, 2017 379,000.00
Jun 30, 2017 402,000.00
Mar 31, 2017 421,000.00
Dec 31, 2016 440,000.00
Sep 30, 2016 458,000.00
Jun 30, 2016 478,000.00
Mar 31, 2016 513,000.00
Dec 31, 2015 513,000.00
Sep 30, 2015 529,000.00
Jun 30, 2015 175,000.00
API Access

Enanta Pharmaceuticals Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=ENTA&period=max&api_key=YOUR_API_KEY